BFA
ARNA

BlackRock Fund Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

BlackRock Fund Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$15.9M Buy
1,122,773
+121,499
+12% +$1.88M ﹤0.01% 2307
2016
Q3 		$17.5M Buy
1,001,274
+46,180
+5% +$766K ﹤0.01% 2142
2016
Q2 		$16.3M Buy
955,094
+60,986
+7% +$1.09M ﹤0.01% 2135
2016
Q1 		$17.6M Buy
894,108
+15,149
+2% +$243K ﹤0.01% 2057
2015
Q4 		$16.7M Sell
878,959
-40,348
-4% -$823K ﹤0.01% 2154
2015
Q3 		$17.6M Buy
919,307
+25,955
+3% +$881K ﹤0.01% 2068
2015
Q2 		$41.5M Sell
893,352
-24,312
-3% -$1.05M 0.01% 1650
2015
Q1 		$40.1M Buy
917,664
+99,365
+12% +$4.62M 0.01% 1659
2014
Q4 		$28.4M Buy
818,299
+72,195
+10% +$2.93M 0.01% 1850
2014
Q3 		$31.3M Sell
746,104
-26,902
-3% -$1.2M 0.01% 1664
2014
Q2 		$45.3M Sell
773,006
-65,478
-8% -$4.12M 0.01% 1461
2014
Q1 		$52.8M Buy
838,484
+31,755
+4% +$2.11M 0.02% 1377
2013
Q4 		$47.2M Sell
806,729
-17,266
-2% -$902K 0.01% 1442
2013
Q3 		$43.4M Buy
823,995
+110,846
+16% +$7.44M 0.01% 1447
2013
Q2 		$54.9M Buy
+713,149
New +$58.2M 0.02% 1139

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.37% 1-Year Est. Return

BlackRock Fund Advisors's ARNA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Arena Pharmaceuticals Inc (ARNA) stake by 12% in Q4 2016, buying an estimated $1.88M and bringing the position to 1,122,773 shares worth $15.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

BlackRock Fund Advisors first reported a position in ARNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $54.9M in Q2 2013. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

  • BlackRock Fund Advisors held 1,122,773 shares of Arena Pharmaceuticals Inc worth $15.9M as of Q4 2016.
  • BlackRock Fund Advisors bought 121,499 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $1.88M.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2307 holding.
  • BlackRock Fund Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Arena Pharmaceuticals Inc position peaked at $54.9M in Q2 2013.
  • 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.